Cohen Klingenstein’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.53M Hold
18,000
0.13% 75
2026
Q1
$3.91M Hold
18,000
0.13% 81
2025
Q4
$4.11M Hold
18,000
0.13% 76
2025
Q3
$4.17M Hold
18,000
0.13% 75
2025
Q2
$3.34M Hold
18,000
0.11% 86
2025
Q1
$3.77M Hold
18,000
0.14% 79
2024
Q4
$3.2M Sell
18,000
-32,500
-64% -$5.98M 0.11% 87
2024
Q3
$9.97M Hold
50,500
0.35% 49
2024
Q2
$8.66M Hold
50,500
0.31% 51
2024
Q1
$9.2M Hold
50,500
0.34% 48
2023
Q4
$7.83M Hold
50,500
0.32% 51
2023
Q3
$7.53M Hold
50,500
0.34% 51
2023
Q2
$6.8M Hold
50,500
0.29% 55
2023
Q1
$8.05M Hold
50,500
0.38% 48
2022
Q4
$8.16M Hold
50,500
0.41% 48
2022
Q3
$6.78M Hold
50,500
0.36% 54
2022
Q2
$7.74M Hold
50,500
0.39% 52
2022
Q1
$8.19M Hold
50,500
0.34% 54
2021
Q4
$6.84M Hold
50,500
0.27% 65
2021
Q3
$5.45M Hold
50,500
0.24% 73
2021
Q2
$5.69M Hold
50,500
0.24% 73
2021
Q1
$5.46M Hold
50,500
0.25% 75
2020
Q4
$5.41M Hold
50,500
0.27% 71
2020
Q3
$4.42M Hold
50,500
0.25% 76
2020
Q2
$4.96M Hold
50,500
0.3% 69
2020
Q1
$3.85M Hold
50,500
0.28% 74
2019
Q4
$4.47M Hold
50,500
0.26% 78
2019
Q3
$3.82M Buy
50,500
+32,500
+181% +$2.23M 0.24% 84
2019
Q2
$1.31M Buy
+18,000
New +$1.41M 0.09% 129

Other funds holding ABBV

Cohen Klingenstein's ABBV Position: Q2 2026 in Review

Cohen Klingenstein held its AbbVie (ABBV) position steady in Q2 2026 at 18,000 shares worth $4.53M. The position accounts for 0.13% of the portfolio, ranked #75.

Cohen Klingenstein first reported a position in ABBV in Q2 2019 and has held it in 29 quarters since. The position peaked at $9.97M in Q3 2024. 1,993 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Cohen Klingenstein held 18,000 shares of AbbVie worth $4.53M as of Q2 2026.
  • Cohen Klingenstein left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.13% of Cohen Klingenstein's portfolio in Q2 2026, its #75 holding.
  • Cohen Klingenstein first reported a position in AbbVie in Q2 2019 and has held it in 29 quarters since.
  • Cohen Klingenstein's AbbVie position peaked at $9.97M in Q3 2024.
  • 1,993 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cohen Klingenstein's 13F filing for Q2 2026, filed 15 Jul 2026.